Teoxane to Present babyGLOW™ — A New Evidence-Based Injection Technique for Skin Quality — at IMCAS 2026

Teoxane babyGLOW^™: A New Technique-Driven Approach to Skin Quality

Skin quality is one of the fastest-growing indications in injectable aesthetics with an estimated ~10% year-on-year growth¹. Teoxane babyGLOW^™ offers a standardized, anatomy-based injection technique with subdermal points to achieve fast, predictable, and homogeneous product distribution while avoiding facial danger zones². Using eight selected facial injection points, is designed to optimize product diffusion and maximize surface light reflection, contributing to a rapid and noticeable improvement in skin radiance/glow².

The technique involves the injection of TEOSYAL^® Puresense Redensity 1 which is a non-crosslinked hyaluronic acid (15 mg/mL) with a Dermostructuring Complex, characterized by high fluidity for homogeneous dermal and subdermal distribution and skin redensification³.

Teoxane Scientific Programming and Expert Education at IMCAS 2026

Teoxane’s scientific contribution will be further highlighted during the Teoxane Symposium, taking place on Thursday, January 29, from 13:30 to 15:30 at Amphi Bleu (Level 2), moderated by Dr. Raul Cetto (UK).

INNOVATING BEAUTY: Teoxane babyGLOW^™ and the RHA^® Kiss Collection

Part I: Teoxane babyGLOW^™: A New Signature Skin Quality Approach

• Lecture: Understanding Skin Quality, Patient Needs, and Trends
• Case Study: Improving Skin Quality in Female and Male Patients

Presented by: Dr. Kieren Bong (UK), Dr. Silvia Caboni (Italy), Prof. Wioletta Baranska Rybak (Poland)

Part II: RHA^® Kiss Collection: The Art and Science of Dynamic Lip Harmonization

• Lecture: Understanding Lip Beauty, Patient Needs, and Trends

Case Study: Dynamic Beautification

Case Study: Dynamic Rejuvenation

Presented by: Dr. Raul Cetto (UK), Dr. Bilur Sezgin (Turkey)

“Medical education is at the core of Teoxane’s scientific mission. At IMCAS, one of the world’s most important medical congresses, our ambition is to bring our educational standards, clinical rigor, and scientific vision directly to the heart of the global aesthetic community.

Teoxane babyGLOW^™ is a clear expression of this approach. The technique was developed in close collaboration with a board of more than 20 expert injectors across six countries and refined through real-world clinical practice. Following a highly successful launch in Spain and strong engagement from physicians, IMCAS represents the opportunity to present this technique to the international community within a robust scientific and educational framework.”

- Mounia Heddad-Masson, Director of Global Medical Education & Medical Affairs

A Complementary In-Clinic and At-Home Approach to Skin Quality

At IMCAS 2026, Teoxane will also highlight its Aesthetic Skincare expertise, developed from the same hyaluronic acid expertise and scientific know-how as Teoxane’s injectable portfolio, the Aesthetic Skincare range is designed to complement and extend clinical outcomes between treatments.

Healthcare professionals visiting the Teoxane booth will be able to discover Teoxane’s latest dermocosmetic innovations, including the recently launched Teoxane Hydra Mask, as well as flagship products such as the RHA^® Serum.

Visit booth L206 (Level 2) throughout the IMCAS 2026 congress to present its scientific contributions, educational programs, and latest clinical innovations.